Providing a Clear Path to Market
Corval™ empowers biopharma leaders to navigate the commercialization process with confidence and achieve the ultimate goal—getting their treatment to patients in need.
A Better Approach to Commercialization
For early- to- mid-stage biopharma companies the months-long commercialization planning process is complex and daunting, requires extensive external resources, and impedes progress towards long-term success.
Corval’s intelligent, intuitive platform provides you clarity and guidance to navigate the commercialization journey and ensure you don’t miss a single step along the path to getting your treatment to patients in need.
Corval was built on decades’ worth of commercialization expertise, so you can feel confident about your long term success.
Corval’s intuitive platform assesses your unique situation and creates a customized, detailed map to illustrate each step on your journey from clinic to patient.
Corval provides a single source of truth to build consensus, fast-track alignment, and plan all facets of your commercialization strategy.
Corval was built on 75,000 data points derived from decades’ worth of commercialization planning expertise.
Corval Adapts to You
Designed for Early- to Mid-Stage Biopharma Companies
Corval dramatically reduces the time, effort, and resources it takes to chart a clear path from clinic to market.
Customized Commercialization Map
A detailed roadmap of your commercialization objectives and activities that adapts to information as you enter it into the platform.
Budget & Resource Plan
A customized schedule of the resources and investments required to support map activities and achieve your organizational objectives.
A single workspace to collaborate on your roadmap and access a trove of commercialization knowledge to help guide your journey and align your evolving team.